Surgical extravascular implantable cardioverter-defibrillator lead implant when transvenous therapy is undesirable
Andor Bik, Hans Römers, Jippe Balt, Edgar Daeter, Martin Swaans, Lucas Boersma · 2026
Read Surgical extravascular implantable cardioverter-defibrillator lead implant when transvenous therapy is undesirable by Andor Bik, Hans Römers, Jippe Balt, Edgar Daeter, Martin Swaans, Lucas Boersma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13492426.txt.
Description
Andor Bik and five colleagues present in 2026 two patients who received a defibrillator lead placed surgically outside the blood vessels, because a vein-threaded lead was judged undesirable. Both patients also needed resynchronization pacing for failing hearts plus protection against dangerous rhythms after earlier cardiac arrests or inherited disease. Standard manufacturer guidance discourages pairing this extravascular defibrillator with pacing therapy, fearing oversensing and inappropriate shocks.
The first patient, a sixty-four-year-old man with inherited heart muscle thickening, had already lived through an arrest, device upgrades, and repeated shocks before the hybrid approach. The combined system, part endocardial and part epicardial pacing alongside the extravascular shock lead, proved technically workable in both cases. The authors stress extensive testing during implant and follow-up, and they caution that the strategy suits only selected patients.
Catalog record
| CREATOR | Andor Bik, Hans Römers, Jippe Balt, Edgar Daeter, Martin Swaans, Lucas Boersma |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12539 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |